ID   DYR1A_RAT               Reviewed;         763 AA.
AC   Q63470;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   02-OCT-2024, entry version 191.
DE   RecName: Full=Dual specificity tyrosine-phosphorylation-regulated kinase 1A;
DE            EC=2.7.11.23 {ECO:0000250|UniProtKB:Q13627};
DE            EC=2.7.12.1 {ECO:0000269|PubMed:22998443};
DE   AltName: Full=Dual specificity YAK1-related kinase;
DE   AltName: Full=Protein kinase minibrain homolog;
DE            Short=MNBH;
DE   AltName: Full=RP86;
GN   Name=Dyrk1a; Synonyms=Dyrk;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG), FUNCTION, TISSUE SPECIFICITY,
RP   PHOSPHORYLATION AT TYR-219; TYR-319 AND TYR-321, AND MUTAGENESIS OF
RP   LYS-188; TYR-219; TYR-319 AND TYR-321.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=8631952; DOI=10.1074/jbc.271.7.3488;
RA   Kentrup H., Becker W., Heukelbach J., Wilmes A., Schuermann A.,
RA   Huppertz C., Kainulainen H., Joost H.-G.;
RT   "Dyrk, a dual specificity protein kinase with unique structural features
RT   whose activity is dependent on tyrosine residues between subdomains VII and
RT   VIII.";
RL   J. Biol. Chem. 271:3488-3495(1996).
RN   [2]
RP   SEQUENCE REVISION.
RA   Kentrup H.;
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9748265; DOI=10.1074/jbc.273.40.25893;
RA   Becker W., Weber Y., Wetzel K., Eirmbter K., Tejedor F.J., Joost H.-G.;
RT   "Sequence characteristics, subcellular localization, and substrate
RT   specificity of DYRK-related kinases, a novel family of dual specificity
RT   protein kinases.";
RL   J. Biol. Chem. 273:25893-25902(1998).
RN   [4]
RP   FUNCTION.
RX   PubMed=18938227; DOI=10.1016/j.neuroscience.2008.09.034;
RA   Sitz J.H., Baumgaertel K., Haemmerle B., Papadopoulos C., Hekerman P.,
RA   Tejedor F.J., Becker W., Lutz B.;
RT   "The Down syndrome candidate dual-specificity tyrosine phosphorylation-
RT   regulated kinase 1A phosphorylates the neurodegeneration-related septin
RT   4.";
RL   Neuroscience 157:596-605(2008).
RN   [5]
RP   SUBCELLULAR LOCATION, FUNCTION, MUTAGENESIS OF LYS-188, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=22767602; DOI=10.1074/jbc.m112.355412;
RA   Yin X., Jin N., Gu J., Shi J., Zhou J., Gong C.X., Iqbal K.,
RA   Grundke-Iqbal I., Liu F.;
RT   "Dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)
RT   modulates serine/arginine-rich protein 55 (SRp55)-promoted Tau exon 10
RT   inclusion.";
RL   J. Biol. Chem. 287:30497-30506(2012).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=22998443; DOI=10.1021/jm301034u;
RA   Tahtouh T., Elkins J.M., Filippakopoulos P., Soundararajan M., Burgy G.,
RA   Durieu E., Cochet C., Schmid R.S., Lo D.C., Delhommel F., Oberholzer A.E.,
RA   Pearl L.H., Carreaux F., Bazureau J.P., Knapp S., Meijer L.;
RT   "Selectivity, cocrystal structures, and neuroprotective properties of
RT   leucettines, a family of protein kinase inhibitors derived from the marine
RT   sponge alkaloid leucettamine B.";
RL   J. Med. Chem. 55:9312-9330(2012).
CC   -!- FUNCTION: Dual-specificity kinase which possesses both serine/threonine
CC       and tyrosine kinase activities (PubMed:18938227, PubMed:22998443,
CC       PubMed:8631952, PubMed:9748265). Exhibits a substrate preference for
CC       proline at position P+1 and arginine at position P-3 (By similarity).
CC       Plays an important role in double-strand breaks (DSBs) repair following
CC       DNA damage (By similarity). Mechanistically, phosphorylates RNF169 and
CC       increases its ability to block accumulation of TP53BP1 at the DSB sites
CC       thereby promoting homologous recombination repair (HRR) (By
CC       similarity). Also acts as a positive regulator of transcription by
CC       acting as a CTD kinase that mediates phosphorylation of the CTD (C-
CC       terminal domain) of the large subunit of RNA polymerase II (RNAP II)
CC       POLR2A (By similarity). May play a role in a signaling pathway
CC       regulating nuclear functions of cell proliferation (By similarity).
CC       Modulates alternative splicing by phosphorylating the splice factor
CC       SRSF6 (PubMed:22767602). Has pro-survival function and negatively
CC       regulates the apoptotic process. Promotes cell survival upon genotoxic
CC       stress through phosphorylation of SIRT1. This in turn inhibits p53/TP53
CC       activity and apoptosis (By similarity). Phosphorylates SEPTIN4, SEPTIN5
CC       and SF3B1 at 'Thr-434' (PubMed:18938227).
CC       {ECO:0000250|UniProtKB:Q13627, ECO:0000250|UniProtKB:Q61214,
CC       ECO:0000269|PubMed:18938227, ECO:0000269|PubMed:22767602,
CC       ECO:0000269|PubMed:22998443, ECO:0000269|PubMed:8631952,
CC       ECO:0000269|PubMed:9748265}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC         Evidence={ECO:0000269|PubMed:22998443};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1; Evidence={ECO:0000269|PubMed:22998443};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC         Evidence={ECO:0000269|PubMed:22998443};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=[DNA-directed RNA polymerase] + ATP = ADP + H(+) + phospho-
CC         [DNA-directed RNA polymerase]; Xref=Rhea:RHEA:10216, Rhea:RHEA-
CC         COMP:11321, Rhea:RHEA-COMP:11322, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:43176, ChEBI:CHEBI:68546,
CC         ChEBI:CHEBI:456216; EC=2.7.11.23;
CC         Evidence={ECO:0000250|UniProtKB:Q13627};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10217;
CC         Evidence={ECO:0000250|UniProtKB:Q13627};
CC   -!- ACTIVITY REGULATION: Inhibited by RANBP9 (By similarity). Inhibited by
CC       harmine, leucettamine B and leucettine L41 (PubMed:22998443).
CC       {ECO:0000250|UniProtKB:Q13627, ECO:0000269|PubMed:22998443}.
CC   -!- SUBUNIT: Interacts with RAD54L2/ARIP4 (By similarity). Interacts with
CC       CRY2 (By similarity). Interacts with RANBP9. Interacts with WDR68 (By
CC       similarity). Interacts with SIRT1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q13627, ECO:0000250|UniProtKB:Q61214}.
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:22767602,
CC       ECO:0000269|PubMed:9748265}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=Q63470-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=Q63470-2; Sequence=VSP_004924;
CC   -!- TISSUE SPECIFICITY: Detected in brain (at protein level). Ubiquitous.
CC       {ECO:0000269|PubMed:22767602, ECO:0000269|PubMed:22998443,
CC       ECO:0000269|PubMed:8631952, ECO:0000269|PubMed:9748265}.
CC   -!- DOMAIN: The polyhistidine repeats act as targeting signals to nuclear
CC       speckles. {ECO:0000250|UniProtKB:Q13627}.
CC   -!- DOMAIN: The histidine-rich domain (HRD) region is intrinsically
CC       disordered and promotes the formation of phase-separated liquid
CC       droplets that enhance its ability to phosphorylate the CTD (C-terminal
CC       domain) of the large subunit of RNA polymerase II (RNA Pol II).
CC       {ECO:0000250|UniProtKB:Q13627}.
CC   -!- PTM: Can also autophosphorylate on serine and threonine residues (in
CC       vitro) (By similarity). Autophosphorylated on numerous tyrosine
CC       residues (PubMed:8631952). {ECO:0000250|UniProtKB:Q13627,
CC       ECO:0000269|PubMed:8631952}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. MNB/DYRK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X79769; CAA56164.1; -; mRNA.
DR   RefSeq; NP_036923.1; NM_012791.3. [Q63470-1]
DR   RefSeq; XP_006248093.1; XM_006248031.3.
DR   RefSeq; XP_008766785.1; XM_008768563.2.
DR   RefSeq; XP_008766786.1; XM_008768564.1.
DR   RefSeq; XP_008766787.1; XM_008768565.2.
DR   AlphaFoldDB; Q63470; -.
DR   SMR; Q63470; -.
DR   BioGRID; 247295; 6.
DR   ELM; Q63470; -.
DR   IntAct; Q63470; 5.
DR   MINT; Q63470; -.
DR   STRING; 10116.ENSRNOP00000042446; -.
DR   BindingDB; Q63470; -.
DR   ChEMBL; CHEMBL5508; -.
DR   DrugCentral; Q63470; -.
DR   GuidetoPHARMACOLOGY; 2009; -.
DR   iPTMnet; Q63470; -.
DR   PhosphoSitePlus; Q63470; -.
DR   PaxDb; 10116-ENSRNOP00000042446; -.
DR   Ensembl; ENSRNOT00000050342.6; ENSRNOP00000042446.5; ENSRNOG00000001662.8. [Q63470-1]
DR   Ensembl; ENSRNOT00000114109.1; ENSRNOP00000096172.1; ENSRNOG00000001662.8. [Q63470-2]
DR   Ensembl; ENSRNOT00055028018; ENSRNOP00055022536; ENSRNOG00055016511. [Q63470-1]
DR   Ensembl; ENSRNOT00060034072; ENSRNOP00060027914; ENSRNOG00060019663. [Q63470-1]
DR   Ensembl; ENSRNOT00065022486; ENSRNOP00065017443; ENSRNOG00065013664. [Q63470-1]
DR   GeneID; 25255; -.
DR   KEGG; rno:25255; -.
DR   UCSC; RGD:2528; rat. [Q63470-1]
DR   AGR; RGD:2528; -.
DR   CTD; 1859; -.
DR   RGD; 2528; Dyrk1a.
DR   eggNOG; KOG0667; Eukaryota.
DR   GeneTree; ENSGT00940000157408; -.
DR   HOGENOM; CLU_000288_5_6_1; -.
DR   InParanoid; Q63470; -.
DR   OrthoDB; 452107at2759; -.
DR   PhylomeDB; Q63470; -.
DR   TreeFam; TF314624; -.
DR   BRENDA; 2.7.12.1; 5301.
DR   Reactome; R-RNO-1538133; G0 and Early G1.
DR   PRO; PR:Q63470; -.
DR   Proteomes; UP000002494; Chromosome 11.
DR   Bgee; ENSRNOG00000001662; Expressed in skeletal muscle tissue and 19 other cell types or tissues.
DR   GO; GO:0030424; C:axon; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005856; C:cytoskeleton; ISO:RGD.
DR   GO; GO:0030425; C:dendrite; ISO:RGD.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0140857; F:histone H3T45 kinase activity; ISO:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kinase activity; ISO:RGD.
DR   GO; GO:0004672; F:protein kinase activity; IDA:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; ISO:RGD.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IDA:UniProtKB.
DR   GO; GO:0008353; F:RNA polymerase II CTD heptapeptide repeat kinase activity; ISS:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0034205; P:amyloid-beta formation; ISO:RGD.
DR   GO; GO:0033173; P:calcineurin-NFAT signaling cascade; IMP:RGD.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; IEP:RGD.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IMP:RGD.
DR   GO; GO:0043518; P:negative regulation of DNA damage response, signal transduction by p53 class mediator; ISO:RGD.
DR   GO; GO:0090310; P:negative regulation of DNA methylation-dependent heterochromatin formation; ISO:RGD.
DR   GO; GO:0031115; P:negative regulation of microtubule polymerization; ISO:RGD.
DR   GO; GO:0048025; P:negative regulation of mRNA splicing, via spliceosome; ISO:RGD.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IGI:ARUK-UCL.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; IBA:GO_Central.
DR   GO; GO:0090312; P:positive regulation of protein deacetylation; ISO:RGD.
DR   GO; GO:0033120; P:positive regulation of RNA splicing; IMP:ARUK-UCL.
DR   GO; GO:0046777; P:protein autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IDA:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0000381; P:regulation of alternative mRNA splicing, via spliceosome; IDA:UniProtKB.
DR   GO; GO:0060043; P:regulation of cardiac muscle cell proliferation; IMP:RGD.
DR   GO; GO:0061050; P:regulation of cell growth involved in cardiac muscle cell development; IMP:RGD.
DR   CDD; cd14226; PKc_DYRK1; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR044131; PKc_DYR1A/1B.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050494; Ser_Thr_dual-spec_kinase.
DR   PANTHER; PTHR24058; DUAL SPECIFICITY PROTEIN KINASE; 1.
DR   PANTHER; PTHR24058:SF121; DUAL SPECIFICITY TYROSINE-PHOSPHORYLATION-REGULATED KINASE 1A; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Kinase; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Transcription; Transcription regulation; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..763
FT                   /note="Dual specificity tyrosine-phosphorylation-regulated
FT                   kinase 1A"
FT                   /id="PRO_0000085933"
FT   DOMAIN          159..479
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          33..56
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          115..136
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          408..442
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          485..540
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          595..625
FT                   /note="Histidine-rich domain (HRD)"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   REGION          596..679
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          744..763
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           117..134
FT                   /note="Bipartite nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        34..56
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        485..528
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        601..624
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        627..679
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        287
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         165..173
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         188
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000305"
FT   BINDING         238..241
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         111
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         140
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         145
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         159
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         177
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         219
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:8631952"
FT   MOD_RES         310
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         319
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:8631952"
FT   MOD_RES         321
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:8631952"
FT   MOD_RES         402
FT                   /note="Phosphothreonine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         449
FT                   /note="Phosphotyrosine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         529
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         538
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61214"
FT   MOD_RES         748
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   MOD_RES         758
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q13627"
FT   VAR_SEQ         70..78
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_004924"
FT   MUTAGEN         188
FT                   /note="K->R: Abolishes autophosphorylation. Retains
FT                   marginal kinase activity towards histones."
FT                   /evidence="ECO:0000269|PubMed:22767602,
FT                   ECO:0000269|PubMed:8631952"
FT   MUTAGEN         219
FT                   /note="Y->F: Reduced autophosphorylation on tyrosine, but
FT                   retains some kinase activity towards histones."
FT                   /evidence="ECO:0000269|PubMed:8631952"
FT   MUTAGEN         319
FT                   /note="Y->F: Suppressed autophosphorylation on tyrosine and
FT                   reduced tyrosine, threonine and serine kinase activity
FT                   towards histones; when associated with F-321."
FT                   /evidence="ECO:0000269|PubMed:8631952"
FT   MUTAGEN         321
FT                   /note="Y->F: Suppressed autophosphorylation on tyrosine and
FT                   reduced tyrosine, threonine and serine kinase activity
FT                   towards histones; when associated with F-319."
FT                   /evidence="ECO:0000269|PubMed:8631952"
SQ   SEQUENCE   763 AA;  85541 MW;  CB5EC7EC4C1F9A47 CRC64;
     MHTGGETSAC KPSSVRLAPS FSFHAAGLQM AAQMPHSHQY SDRRQPNISD QQVSALSYSD
     QIQQPLTNQV MPDIVMLQRR MPQTFRDPAT APLRKLSVDL IKTYKHINEV YYAKKKRRHQ
     QGQGDDSSHK KERKVYNDGY DDDNYDYIVK NGEKWMDRYE IDSLIGKGSF GQVVKAYDRV
     EQEWVAIKII KNKKAFLNQA QIEVRLLELM NKHDTEMKYY IVHLKRHFMF RNHLCLVFEM
     LSYNLYDLLR NTNFRGVSLN LTRKFAQQMC TALLFLATPE LSIIHCDLKP ENILLCNPKR
     SAIKIVDFGS SCQLGQRIYQ YIQSRFYRSP EVLLGMPYDL AIDMWSLGCI LVEMHTGEPL
     FSGANEVDQM NKIVEVLGIP PAHILDQAPK ARKFFEKLPD GTWSLKKTKD GKREYKPPGT
     RKLHNILGVE TGGPGGRRAG ESGHTVADYL KFKDLILRML DYDPKTRIQP YYALQHSFFK
     KTADEGTNTS NSVSTSPAME QSQSSGTTSS TSSSSGGSSG TSNSGRARSD PTHQHRHSGG
     HFAAAVQAMD CETHSPQVRQ QFPAPLGWSG TEAPTQVTVE THPVQETTFH VAPQQNALHH
     HHGNSSHHHH HHHHHHHHHG QQALGNRTRP RVYNSPTNSS STQDSMEVGH SHHSMTSLSS
     STTSSSTSSS STGNQGNQAY QNRPVAANTL DFGQNGAMDV NLTVYSNPRQ ETGIAGHPTY
     QFSANTGPAH YMTEGHLTMR QGADREESPM TGVCVQQSPV ASS
//
